Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Clinical Trial Supply Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Clinical Trial Supply Market Trends and Forecast

The future of the clinical trial supply market looks promising with opportunities in the pharmaceutical & biotechnology companies, contract research organisations, and medical device companies segment. The global clinical trial supply market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of 7.7% from 2023 to 2028. The major drivers for this market are increasing R&D expenditure by the pharmaceutical and biotechnology companies, growing prevalence of diseases, and the globalization of clinical trials.
Clinical Trial Supply Market by Service, Type, Therapeutic Area, and End Use Industry

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below. 
Clinical Trial Supply Market by Segments

Clinical Trial Supply Market by Segment

The study includes trends and forecast for the global clinical trial supply market by service, type, therapeutic area, end use industry, and region, as follows:

Clinical Trial Supply Market by Service [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Logistics & Distribution
  • Storage & Retention
  • Packaging, Labeling, and Blinding
  • Manufacturing
  • Comparator Sourcing

Clinical Trial Supply Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Small-Molecules
  • Biologic Drugs
  • Medical Devices

Clinical Trial Supply Market by Therapeutic Area [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Oncology
  • CNS and Mental Disorders
  • Cardiovascular Diseases
  • Digestive Disorders
  • Infectious Diseases
  • Metabolic Disorders
  • Immunology
  • Blood Disorders

Clinical Trial Supply Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organisations (CROs)
  • Medical Device Companies

Clinical Trial Supply Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clinical Trial Supply Companies

Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, clinical trial supply companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the clinical trial supply companies profiled in this report include- 

Clinical Trial Supply Market Insights

  • Lucintel forecasts that oncology are expected to remain the largest segment over the forecast period as pharmaceutical and biotechnology companies are focusing on bringing innovative cancer drugs into the market.
  • Within this market, pharmaceutical and biotechnology is expected to remain the largest segment over the forecast period due to increasing in number of clinical trails being conducted pharmaceutical and biotechnology companies to develop new drugs and treatment that drives the market.
  • APAC is expected to witness the highest growth over the forecast period due to growing demand of new and effective drugs and the region is large with diverse population that provides a large pool of potential clinical trial participant for drug development companies.

Features of the Clinical Trial Supply Market

  • Market Size Estimates: Clinical trial supply market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Clinical trial supply market size by various segments, such as service, type, therapeutic area, end use industry, and region.
  • Regional Analysis: Clinical trial supply market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different service, type, therapeutic area, end use industry, and region for the clinical trial supply market.
  • Strategic Analysis: This includes M&A, new type development, and competitive landscape for the clinical trial supply market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the clinical trial supply market size?
Answer: The global clinical trial supply market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for clinical trial supply market?
Answer: The global clinical trial supply market is expected to grow with a CAGR of 7.7% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the clinical trial supply market?
Answer: The major drivers for this market are increasing R&D expenditure by the pharmaceutical and biotechnology companies, growing prevalence of diseases, and the globalization of clinical trials.
Q4. What are the major segments for clinical trial supply market?
Answer: The future of the clinical trial supply market looks promising with opportunities in the pharmaceutical & biotechnology companies, contract research organisations, and medical device companies.
Q5. Who are the key clinical trial supply companies?
Answer: Some of the key clinical trial supply companies are as follows:
  • Thermo Fisher Scientific
  • Marken
  • Catalent
  • Eurofins Scientific
  • PRA Health Sciences
Q6. Which clinical trial supply segment will be the largest in future?
Answer: Lucintel forecasts that oncology are expected to remain the largest segment over the forecast period as pharmaceutical and biotechnology companies are focusing on bringing innovative cancer drugs into the market.
Q7. In clinical trial supply market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to growing demand of new and effective drugs and the region is large with diverse population that provides a large pool of potential clinical trial participant for drug development companies.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q.1. What are some of the most promising, high-growth opportunities for the clinical trial supply market by service (logistics & distribution, storage & retention, packaging, labeling, and blinding, manufacturing, and comparator sourcing), type (small-molecules, biologic drugs, and medical devices), therapeutic area (oncology, CNS and mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, immunology, and blood disorders), end use industry(pharmaceutical & biotechnology companies, contract research organisations, and medical device companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2.  Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

For any questions related to clinical trial supply market or related to clinical trial supply companies, clinical trial supply market size, clinical trial supply market share, clinical trial supply analysis, clinical trial supply market growth, clinical trial supply market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
 
1. Executive Summary
 
2. Global Clinical Trial Supply Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2017 to 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Clinical Trial Supply Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Clinical Trial Supply Market by Service
3.3.1: Logistics & Distribution
3.3.2: Storage & Retention
3.3.3: Packaging, Labeling, and Blinding
3.3.4: Manufacturing
3.3.5: Comparator sourcing
3.4: Global Clinical Trial Supply Market by Type
3.4.1: Small-molecules
3.4.2: Biologic drugs
3.4.3: Medical devices
3.5: Global Clinical Trial Supply Market by Therapeutic Area
3.5.1: Oncology
3.5.2: CNS and Mental Disorders
3.5.3: Cardiovascular Diseases
3.5.4: Digestive Disorders
3.5.5: Infectious Diseases
3.5.6: Metabolic Disorders
3.5.7: Immunology
3.5.8:Blood Disorders
3.6: Global Clinical Trial Supply Market by End Use Industry
3.6.1: Pharmaceutical & Biotechnology companies
3.6.2: Contract Research Organisations (CROs)
3.6.3: Medical Device Companies
 
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Global Clinical Trial Supply Market by Region
4.2: North American Clinical Trial Supply Market
4.2.1: North American Clinical Trial Supply Market by Therapeutic Area: Oncology, CNS and Mental Disorders, Cardiovascular Diseases, Digestive Disorders, Infectious Diseases, Metabolic Disorders, Immunology, and Blood Disorders
4.2.2: North American Clinical Trial Supply Market by End Use Industry: Pharmaceutical & Biotechnology companies, Contract Research Organisations (CROs), and Medical Device Companies
4.3: European Clinical Trial Supply Market
4.3.1: European Clinical Trial Supply Market by Therapeutic Area: Oncology, CNS and Mental Disorders, Cardiovascular Diseases, Digestive Disorders, Infectious Diseases, Metabolic Disorders, Immunology, and Blood Disorders
4.3.2: European Clinical Trial Supply Market by End Use Industry: Pharmaceutical & Biotechnology companies, Contract Research Organisations (CROs), and Medical Device Companies
4.4: APAC Clinical Trial Supply Market 
4.4.1: APAC Clinical Trial Supply Market by Therapeutic Area: Oncology, CNS and Mental Disorders, Cardiovascular Diseases, Digestive Disorders, Infectious Diseases, Metabolic Disorders, Immunology, and Blood Disorders
4.4.2: APAC Clinical Trial Supply Market by End Use Industry: Pharmaceutical & Biotechnology companies, Contract Research Organisations (CROs), and Medical Device Companies
4.5: ROW Clinical Trial Supply Market 
4.5.1: ROW Clinical Trial Supply Market by Therapeutic Area: Oncology, CNS and Mental Disorders, Cardiovascular Diseases, Digestive Disorders, Infectious Diseases, Metabolic Disorders, Immunology, and Blood Disorders
4.5.2: ROW Clinical Trial Supply Market by End Use Industry: Pharmaceutical & Biotechnology companies, Contract Research Organisations (CROs), and Medical Device Companies
 
5. Competitor Analysis
5.1: Type Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
 
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Clinical Trial Supply Market by Service
6.1.2: Growth Opportunities for the Global Clinical Trial Supply Market by Type
6.1.3: Growth Opportunities for the Global Clinical Trial Supply Market by Therapeutic Area 
6.1.4: Growth Opportunities for the Global Clinical Trial Supply Market by End Use Industry
6.1.5: Growth Opportunities for the Global Clinical Trial Supply Market by Region 
6.2: Emerging Trends in the Global Clinical Trial Supply Market 
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Clinical Trial Supply Market 
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Trial Supply Market 
6.3.4: Certification and Licensing
 
7. Company Profiles of Leading Players
7.1: Thermo Fisher Scientific
7.2: Marken
7.3: Catalent
7.4: Eurofins Scientific
7.5: PRA Health Sciences
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Clinical Trial Supply Market: Trends, Opportunities and Competitive Analysis [2023-2028] Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Clinical Trial Supply Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?

Follow us on